Consensus eHealth, Inc.

Equities

EHTH

US28238P1093

Real-time Estimate Cboe BZX 10:24:39 2024-03-28 am EDT 5-day change 1st Jan Change
5.92 USD +0.17% Intraday chart for eHealth, Inc. +2.68% -31.94%

Evolution of the average Target Price on eHealth, Inc.

Price target over the last 5 years

History of analyst recommendation changes

8f246ef9.h9VubmOgAr0GtXJ6v_eJ3grkkNo11D-9tLBEB7Owgw8.05NDDQ32MuRi2BAe-Z29u06c3YVXkQ3x8-N2YOfzs2LdpBgkJZNKx1SYJw~4578ca5fd3d87894fa15cce0b4249954
Deutsche Bank Adjusts eHealth Price Target to $5 From $8, Maintains Hold Rating MT
Craig-Hallum Downgrades eHealth to Hold From Buy, Cuts Price Target to $7 From $11 MT
Deutsche Bank Adjusts eHealth Price Target to $8 From $10, Maintains Hold Rating MT
Deutsche Bank Adjusts eHealth Price Target to $10 From $5, Maintains Hold Rating MT
Citigroup Adjusts eHealth's Price Target to $9 From $7, Keeps Neutral Rating MT
Citigroup Adjusts eHealth's Price Target to $7 From $10, Keeps Neutral Rating MT
Citigroup Adjusts Price Target on eHealth to $10 From $4.50, Maintains Neutral Rating MT
Credit Suisse Raises eHealth's Price Target to $10 From $4, Says Concerns on Liquidity, Business Model Subside; Keeps Neutral Rating MT
RBC Cuts Price Target on eHealth to $13 From $16, Maintains Sector Perform Rating MT
Deutsche Bank Raises eHealth's Price Target to $5 From $4, Maintains Hold Rating MT
Credit Suisse Lowers eHealth's Price Target to $4 From $10, Maintains Neutral Rating MT
Deutsche Bank Adjusts eHealth Price Target to $4 From $10, Maintains Hold Rating MT
Credit Suisse Lowers eHealth's PT to $10 from $13, Reduces Sales Estimates As Company Takes Prudent Approach to Spending; Maintains Neutral Rating MT
Truist Lowers eHealth's Price Target to $8 From $12, Maintains Hold Rating MT
Citigroup Adjusts eHealth's Price Target to $9 From $13, Maintains Neutral Rating MT
Deutsche Bank Adjusts eHealth Price Target to $10 From $19, Maintains Hold Rating MT
Credit Suisse Lowers eHealth's Price Target to $13 from $16 After Relatively In Line Q1 Results, Lowers 2022, 2023 Revenue Estimates; Keeps Neutral Rating MT
Citigroup Downgrades EHealth to Neutral From Buy, Adjusts Price Target to $15 From $37 MT
RBC Cuts Price Target on EHealth to $17 From $28 After Q4 Results, 2022 Guidance Miss Expectations; Sector Perform Kept MT
Credit Suisse Lowers eHealth's Price Target to $16 from $31 After Lower-than-Consensus Q4 Results, Keeps Neutral Rating MT
Truist Securities Downgrades eHealth to Hold from Buy, Adjusts Price Target to $15 From $40 MT
Evercore ISI Cuts EHealth to In-Line From Outperform, Price Target to $15 From $35 MT
Barclays Downgrades eHealth to Equalweight from Overweight, Adjusts Price Target to $22 from $45 MT
Credit Suisse Downgrades eHealth to Neutral from Outperform, Says Among Potential M&A Targets; Lowers PT to $31 from $45 MT
Citigroup Adjusts eHealth's Price Target to $37 from $45, Keeps Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
5.91 USD
Average target price
8.358 USD
Spread / Average Target
+41.41%
High Price Target
13 USD
Spread / Highest target
+119.97%
Low Price Target
5 USD
Spread / Lowest Target
-15.40%

Consensus detail

Consensus revision (last 18 months)

Analysts covering eHealth, Inc.

Deutsche Bank Securities
Craig-Hallum
Citigroup
RBC Capital Markets
Credit Suisse
Truist Securities
Evercore ISI
Barclays
Goldman Sachs
Raymond James
Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings